CeriBell Inc - CBLL Earnings per share for the last twelve months

CeriBell EEG (CBLL) - corporate logo

CeriBell, Inc. (CBLL) delegates electronics assembly to Asian contractors and data storage to external providers while retaining ownership of its neural network algorithms. Supply chain stability is ensured through procurement diversification and the establishment of backup warehouses. This chart's linear price action reflects an EPS TTM of -34.60. Business growth relies on partnerships with hospitals integrating AI diagnostic systems into the operations of intensive care units.

ceribell.com (CBLL): Earnings per share for the last twelve months from 11/23/2025 to 11/13/2026

Financial and market metric breakdowns for CeriBell Corp (CBLL)

- market price and analyst price targets:
Market Chart ceribell.com|CBLL - Analyst Consensus Forecast
- issuer market value details:
Market Value CeriBell Inc|CBLL - Enterprise Value
- balance sheet net asset value indicators:
Net Asset Value per Share CeriBell|CBLL - Company Book Value|Market Value to Book Value Ratio ceribell.com|CBLL - Aggregate Company Assets
- company total debt and liquidity indicators:
Debt to Equity CeriBell, Inc.|CBLL - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital CeriBell EEG|CBLL - Company Aggregate Debts|Debts to Net Assets CeriBell Inc|CBLL - Company Long-Term Debt|Company Short-Term Indebtedness CeriBell|Quick Liquidity Indicator ceribell.com
- net income and valuation ratios data:
CBLL - Net Income|Company Profit Forecast CeriBell, Inc.|CBLL - P/E Multiple|Projected Price to Earnings CeriBell Inc|CBLL - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CeriBell Inc|CBLL - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months CeriBell|CBLL - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months ceribell.com|CBLL - Earnings per share growth in current year|Projected earnings per share growth rate for next year CeriBell, Inc.
- revenue and sales details:
CBLL - Revenue and Sales Volume|Company Expected Sales Volume ceribell.com|CBLL - Market Cap to Revenue|Forward P/S Multiple CeriBell Inc
Fundamental company valuation:CBLL (ceribell.com)
Flagship merchandise of CeriBell EEG

Identifying fundamentally resilient assets requires an analysis of real profit dynamics. This indicator measures the percentage change in net income per share over the last twelve months, reflecting the growth rate of business efficiency. For CeriBell, Inc. (CBLL), this metric confirms the monetization of clinic dependence on proprietary consumables for EEG systems. By evaluating the 12-month EPS YoY growth rate, an investor can determine the sustainability of this high-margin model.

Competitor analysis

Net earnings per share for the last four quarters biogen.com BIIB|NBIX: Net earnings per share (EPS TTM)|RGC (Regencell Bioscience Ltd) - Earnings per share for the last twelve months|AXSM (Axsome Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months ACADIA Corp ACAD|Earnings per share for the last twelve months Xenon Pharmaceuticals (XENE)|Earnings per share for the last twelve months VKTX (vikingtherapeutics.com)|Earnings per share for the last twelve months Supernus SUPN|Catalyst Pharma - Earnings per share for the last twelve months|DNLI: Net earnings per share for the last 12 months|Earnings per share for the trailing year HRMY (Harmony Corp)|BHVN: Net earnings per share (EPS TTM)|AMLX - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Trevi Therapeutics, Inc.|Earnings per share for the last 12 months PRAX (Praxis Precision Medicines Inc)|Net earnings per share (EPS TTM) AVXL|Net earnings per share for the last 12 months Prothena Biosciences PRTA|Alector - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters annexonbio.com (ANNX)|Omeros Corp. - Net earnings per share (EPS TTM)|Neurogene Inc (NGNE) - Net earnings per share for the last 12 months|ACIU: Net earnings per share (EPS TTM)|VYGR (Voyager Corp) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Neumora Therapeutics|Earnings per share for the last twelve months SCLX|Earnings per share for the last twelve months Tevogen Bio (TVGN)|Earnings per share for the last twelve months ACOG (alphacognition.com)|Earnings per share for the last twelve months Cognition Therapeutics CGTX|IKT: Earnings per share for the last 12 months|Cassava Sciences, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Assertio Holdings, Inc.|COYA (coyatherapeutics.com) - Net earnings per share for the last 12 months|Vistagen (VTGN) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Ovid Therapeutics Inc|ABOS: Earnings per share for the trailing year|Earnings per share for the last twelve months CervoMed Inc. (CRVO)|ATHE - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CLNN (Clene)|PEPG - Net earnings per share for the last 12 months|Jupiter Neurosciences Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Relmada Corp|Annovis Bio, Inc. (ANVS) - Earnings per share for the last twelve months|Grace Therapeutics - Earnings per share for the trailing year|AIFF (Firefly Neuroscience) - Net earnings per share (EPS TTM)|ANEW Medical, Inc. (KLTO) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) NRSN|Earnings per share for the last twelve months RVPH (Reviva Pharmaceuticals, Inc.)|Net earnings per share (EPS TTM) MTVA (MetaVia)|neuraxis.com (NRXS) - Net earnings per one share for the last twelve months|HSDT - Earnings per share for the last twelve months|PASG: Earnings per share for the last twelve months|bionomics.com.au (NEUP) - Earnings per share for the last twelve months|NERV (Minerva) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ATHA|ADXN: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALZN|Net earnings per share for the last four quarters cyclerion.com|Earnings per share for the last twelve months Protagenic Therapeutics, Inc. PTIX|KTTA: Earnings per share for the last 12 months|Cortigent Medical - Net earnings per share (EPS TTM)|avenuetx.com (ATXI) - Net earnings per share for the last 12 months|BCLI (BrainStorm Cell Therapeutics) - Net earnings per share for the last 12 months|CARA - Net earnings per share for the last four quarters|CHRO (Chromocell Therapeutics Corporation) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Eliem (ELYM)|Net earnings per share (EPS TTM) ITCI|Earnings per share for the last twelve months LBPH (longboardpharma.com)|Earnings per share for the last twelve months Marinus Pharmaceuticals, Inc. MRNS|NKGen Biotech Inc - Earnings per share for the last twelve months|NRBO - Earnings per share for the last twelve months|SAGE: Earnings per share for the last twelve months|Synaptogenix, Inc. (SNPX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months TRVN|VIGL (Vigil Neuroscience Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Anew Medical Inc. WENA|Net earnings per share for the last 12 months CERE (Cerevel)